Emerging Markets and Differential Pricing Policies: A Question of Global Health?
DOI:
https://doi.org/10.5912/jcb568Keywords:
differential pricing, access to medicines, development, emerging marketsAbstract
Over the past decades, global health has moved from discrete disease campaigns to major developmental strategies. However, medication affordability remains an important, unsolved challenge for industry and the global community. This effort requires coordinated actions by multiple stakeholders. Industry can play a specific role through responsible, differentiated pricing of medicines. Public policies should incentivize such pricing policies rather than discouraging them by external reference pricing or parallel trade. Providing opportunities for industry to invest in emerging markets sustainably, patients will benefit from greater access and support attainment of the UN Millennium Development Goals.
References
. Koplan, J.P., Bond, T.C., Merson, M.H. et al. (2009). Towards a common definition of global health. Lancet. 373(9679):1993-1995.
. World Health Organization. (2007). Working for Health: An Introduction to the World Health Organization. http://www.who.int/about/brochure_en.pdf, accessed May 17, 2012.
. U.N. Development Programme. (2012). The Millenium Development Goals. http://www.undp.org/content/undp/en/home/mdgoverview.html, accessed May 17, 2012.
. International Federation of Pharmaceutical Manufacturers and Associations. (2011). The Pharmaceutical Industry and Global Health: Facts and Figures. http://www.ifpma.org/fileadmin/content/Publication/2011/2011_The_Pharmaceutical_Industry_and_Global_Health_low_ver2.pdf, accessed May 18, 2012.
. Yadav, P. (2010). Differential Pricing for Pharmaceuticals. UK Department for International Development. http://www.dfid.gov.uk/Documents/publications1/prd/diff-pcing-pharma.pdf, accessed March 13, 2012.
. Merck & Co. (2011). Access to Health: Statement of Guiding Principles. http://www.merck.com/csr-bridge/access-to-health-merck.pdf, accessed May 18, 2012.
. Taylor, L. (2011). Drug prices across the EU vary by up to 25%; study. Pharma Times, 27 May. http://www.pharmatimes.com/article/11-05-27/Drug_prices_across_the_EU_vary_by_up_to_25_study.aspx, accessed May 18, 2012.
. Ramsey, F. (1927) A Contribution to the Theory of Taxation. Economic Journal 37(145):47-61.
